📇 Rhumatologue ·
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Référence presse grand public
Cité 10 fois dans les médias — pédagogie reconnue
✨ Génération du profil synthétique IA en cours…
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 Ouest-France · 12/02/2014
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQMHZELVA3a2p0dk5DR2JVVkJta3otZmNEODZsLTFrM01pLXhlV3R6dzRxMVYxNEtVMHl6RWpzSTZURWFXN0tUNXdJQXY0T3hIb1prRnp1YjczX3Jwd0FTSUFuM1E2Q19POWRjN0lpbGlIcHBpdXhDeUVpTFFmTGZTbjc1SVVwRXdneC1Tb29VbXhkVDhmRTlWaGFHUENza1h5M0d4ZnRhWmJjeEc2?oc=5" target="_bl
📰 Sud Ouest · 02/02/2024
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQOFV6RkJteDZnaXhHbWNGbU5JUG85Y21HUWd6b2RHYWRXeFVMNjhPbDV0X3pJSnM4Q0dvMGl3RUVDWVc5RGlnSFhSUlZvYkFNOVFfMUlHdVpkSGtjQTFFdHFqSmw3VlB6Y09YdFlEQUZfUlhPSjhRQ1ZqVmxheWU2RFZVclMtWktrV0pwUHFMbFA1Tjd1b1hFaDluVmVqZnZYTFhFNDhtUnVqZ0FwYWhVZjNmdVhncmJTb1
📰 Le Télégramme · 07/07/2012
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPVGlxZEFoXy1GeEp5clQ2bWhFY045bGtZVENHUmFsaG9BTmYwUG9BeV9lRDFxU05YOHdUTjk4THBKX0ZYLVRUcmx2VEtPODk5MnhhaE02Z2Y2R2pPbGhJaVd5azZtRUViSm1yRmZneWJhV1ZxeDVuNUZiZXlkcDNrTGVqVHpGYm53R1hsV1VQRjZLWE5CWkF5dmVVTVNLSXVMQWdVQjkzRWtFYWI0SDhldw?oc=5" targe
📰 Le Progrès · 12/09/2025
<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxNdUdZeDFXcms1cFZYMG9hSFd3OWx0SDljQUpQUm5QWmU2a1VKMUlfdlY4SDlVYzk0MjJ6U182Zzh3amk2Y2plNGlTNFpfQVpoMm8tQXdxaTR5TnpjX2l5YWhXd2gxV3RTZUFncnI4X3RaWFpNMElYN2o2bXZEZ2dWeUF6ZV91OUY1SEhnQVlnT1Z3SmhDb29QMHl0QjZvbGd6YjhUdUdaZ2FVU0I0WXp1c2pMWDNUSmFQT1
📰 Ouest-France · 30/05/2013
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQTDlVSGZMUmVnS2NJZFNtTHU1ZlJvZGFqSE1XUzlqWE5EU29XVWU5SDlFc0JSUnpkX3VMTzFvMjIySVM1Vy1qWHM0aGVjWFp3bndQUFBFLTN2NkluUzZBY0dyb3VOQzdoLTRibzAtRDIxR25mTFVGckI4SjZlS255MU5jWUxzbzg3VXRrVHM4Z2JzQVoxWWJKeTBzSUg?oc=5" target="_blank">Quoi d'neuf doct
📰 Sud Ouest · 14/02/2020
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxORmYwQkRPdW9uX1NJOW9lTWE2MXc2N1ZiQi1IbUZqc0NhTUxaWnNSYlBCTmhnNTM3M01jWGNpQ21KR21rRlNFZ29FQlhmNlVCNEp3ZFhZbFFOaDNzZ2FSVElpR3paNHVHVHJqZXpwcmlHNTJMU1ZMN3FPRGd0Z1UwbkM2YzNJNndXZnVaelYtaExXc2I3eE8xZ0ctV3ZLQQ?oc=5" target="_blank">Pompiers : ha
📰 Le Progrès · 14/01/2022
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPdlFmalFfUjFROG4wdHR2OU9KWVFZNS1rVTNUeVI0TDBvSWQ1cVZ5bVB2eFRGRHYwLTFOUHpkUFQ5SHJRRHg1VVpFRVY3YnJWajlibVNPWDZjWVpxYUhDN1lQcGtkMHNMRThXVVBacnlvMXZIRWw1ci0yUk1sekVfcnkwYk11WjREQzE2TWZvSEhGRm50d1FjWGNpM0RSTEU1ZGw1RjNqbw?oc=5" target="_blank">S
📰 Sud Ouest · 17/02/2023
<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxOT2E3NUxIQ1lyTzZYVUpuOGw0MVhuSVI4TG5PSlcxNl82dU1OVEU0dkpMaExXRVB0cUJzenFfT0lZYmsyNGp4T1lFNHBHWFR4WmFfdThHUV9qQ3lwMHhrLTR6RE1FazFncGMxaUVRaFlOWEt1QnctdFZrZkpCc2IxczlrUl85LVZoRHZ3Smp1N09yNDQyeDczcXpkYUplOUg2NFdoUHVuY1lDcXBPamVqRHd6eUNkSzBaR0
📰 Ouest-France · 17/04/2014
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOWHlqcGxncmNiZ2ZUUmNKdmIwOXdKZnljNG1JelhHWnpJSFFERjVGRklBbVFWQ2txY3pmX3pZbGVucXB5czQyaEdScVhodWlKanpuOWNXc19rRkxzTXlwYm0ta0ZEWWlSNnJma0pkXzU3UnBaeHBoLUExTG5ieHp5bmFUckhEYkJkcmZ1VjlZc0owbk5vNDIxWlM2V3lwOUdjU3dmUVNPY1huQQ?oc=5" target="_blan
📰 Le Progrès · 28/11/2017
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQSm9ySmdsSVdGNGI5UTJmNlVqTXZYXzR1d0pWQmN1eVFQMlRsWFk1bFk2YXkyNVRrMlI5Yy1fUlhWa3VfT2xSLU93OWNnbXlMblI4bVdSajJnak9HS2pXZExPM3cyTU02M0xiVl9uc3dfNzdTbkVkVkx4OW13THFRQW92eURTUTZVTXpFVEFNWFBUU1NBMEtNMm5IZkFDNzJlbXVnem9iMi1CRFFiYzlz?oc=5" target=
RMD open · 2024
Introduction The therapeutic interest of targeting B-cell activating factor (BAFF) in Sjögren’s disease (SjD) can be suspected from the results of two phase II clinical trials but has not been evaluated in an animal model of the disease. We aimed to evaluate the therapeutic efficacy of this strategy on dryness and salivary gland (SG) infiltrates in the NOD mouse model of SjD. Material and methods Female NOD mice between ages 10 and 18 weeks were treated with a BAFF-blocking monoclonal antibody, Sandy-2 or an isotype control. Dryness was measured by the stimulated salivary flow. Salivary lymphocytic infiltrates were assessed by immunohistochemistry. Blood, SGs, spleen and lymph-node lymphocyte subpopulations were analysed by flow cytometry. SG mRNA expression was analysed by transcriptomic analysis. Results BAFF inhibition significantly decreased SG lymphocytic infiltrates, which was inversely correlated with salivary flow. The treatment markedly decreased B-cell number in SGs, blood, lymph nodes and spleen and increased Foxp3+ regulatory and CD3+CD4−CD8− double negative T-cell numbers in SGs. Conclusion A monoclonal antibody blocking BAFF and depleting B cells had therapeutic effectiveness in the NOD mouse model of SjD. The increase in regulatory T-lymphocyte populations might underlie the efficacy of this treatment.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
RMD open · 2024 · Journal Article
Felten R, Foray AP, Schneider P, Marquet C, et al.